Product Code: BHR0856SA
"Global Minimally Invasive Neurosurgical Systems Market to Reach $1.23 Billion by 2030."
Market Report Coverage - Minimally Invasive Neurosurgical Systems
Market Segmentation
- Neuromicroscopy
- Neuronavigation
- Optical Neuronavigation Systems
- Electromagnetic Neuronavigation Systems
- Neuroendoscopy
- Rigid Neuroendoscopy Systems
- Flexible Neuroendoscopy Systems
- Neurosurgical Robotics
- Systems
- Instruments and Accessories
- Services
Regional Segmentation
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Netherlands
- Switzerland
- Rest-of-Europe
- Asia-Pacific
- Japan
- China
- South Korea
- India
- Australia and New Zealand
- Singapore
- Rest-of-Asia-Pacific
- Rest-of-the-World (Latin America and Middle East and Africa)
Growth Drivers
- Increasing Elderly Population on the Global Level
- Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
- Availability of Technological Advanced Products in the Field of Neurosurgical Procedures
Market Challenges
- Shortage of Skilled Professionals
- Restrictive Reimbursement Landscape
Market Opportunities
- Development of Long-Distance Teleoperated Surgical Robotic Systems
- Development of Augmented Reality in the Operating Field
Key Companies Profiled
Corindus vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation
Key Questions Answered in this Report:
- What is the current market size and future potential of the minimally invasive neurosurgical products?
- What is the current market share and growth share of the different products in the market?
- What are the guidelines implemented by different government bodies to regulate the approval of minimally invasive neurosurgical systems?
- What are the major market drivers, restraints, and opportunities in the global minimally invasive neurosurgical systems market?
- What is the impact of the COVID-19 pandemic on the market?
- Which technology is being researched and worked upon to improve the neurosurgical systems?
- Who are the leading players holding dominating shares in the global minimally invasive neurosurgical systems market?
- What are the key development and strategies incorporated by the players of the global minimally invasive neurosurgical systems market to sustain the competition and retain their supremacy?
- Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global minimally invasive neurosurgical systems market?
Overview on the Global Minimally Invasive Neurosurgical Systems Market
Technological advancements in neurosurgical systems and instruments have led to major breakthroughs and disruptive phases in the healthcare landscape across the world. The inventions of the digital camera further aiding in the visualization of the operating field and smaller surgical instruments, which can be passed through endoscopes, produces less trauma to a patient due to small incisions on the skull. Thus, the preference for minimally invasive neurosurgeries continued to grow over the decades, this led to the emergence of robotic-assisted surgeries because of the need for millimeter accuracy and precision, which cannot be done freehand by neurosurgeons. The idea of robotic-assisted neurosurgical procedures is being driven by the increasing need for using multiple surgical instruments through multiple access ports of the endoscopes to support minimally invasive neurosurgeries.
Global Minimally Invasive Neurosurgical Systems Market Forecast, 2020-2030
The global minimally invasive neurosurgical systems market was valued at $417.7 million in 2019 and is anticipated to reach $1,237.6 million by 2030, growing at a CAGR of 11.8% during the forecast period 2020-2030.
The evolution of technologies and methodologies has a huge impact on the global minimally invasive neurosurgical systems market. Several factors such as the shift in preference for safer options than open brain surgeries, increasing preference for surgical instruments with more dexterity, increasing affordability of the procedure, and technological advances in the field of Artificial Intelligence (AI), Augmented Reality (AR), haptics, and telesurgery are expected to play a key role in the growth of the market. The neurosurgical robot is likely to grow because of a more connected interface, motion scaling, and tremor filtration. The high installation and maintenance cost of neurosurgical robotic systems is one of the key factors restraining the growth in the adoption of surgical robotics technology. The neurosurgical systems like neuroendoscopy, neuronavigation, and neuromicroscopy will see steady growth due to the upgradation in the technologies they use. Additionally, a lack of skilled professionals will be a challenge to the growth of this market.
Competitive Landscape
The global minimally invasive neurosurgical systems market consists of large and new entrant manufacturers and vendors. Presently, with the increasing adoption of neurosurgical robotics systems and neuronavigation systems in healthcare, the manufacturers in the market have a decent number of opportunities to expand their offerings and to make a strong foothold in the market.
During January 2015- August 2020, the market witnessed approximately 12 new offerings, six partnerships, alliances and business expansions, 17 regulatory and legal approvals, four funding activities, and five mergers and acquisitions. Most of the manufacturers in the market acquires and partnerships with not only other companies but also the university and research institutions as the key strategies to develop a new version of neurosurgical systems to attain a strong financial position in the market.
The key players contributing to the global minimally invasive neurosurgical systems market are Corindus Vascular Robotics Inc. (Siemens Healthineers), Microbot Medical Inc., Synaptive Medical Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., B. Braun Melsungen AG, Olympus Corporation, Renishaw Plc, Medtronic Plc, Leica Microsystems (Danaher Corporation), Carl Zeiss AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Brainlab AG, Monteris Medical Corporation.
Table of Contents
1 Product Definition
2 Scope of Research Study
- 2.1 Key Questions Answered in the Report
- 2.2 Forecast Period Selection Criteria
3 Research Methodology
- 3.1 Primary Research
- 3.2 Secondary Research
- 3.3 Data Sources and Categorization
- 3.4 Market Estimation and Forecast Methodology
- 3.5 Data Triangulation
4 Competitive Landscape
- 4.1 Key Developments and Strategies
- 4.1.1 Regulatory and Legal
- 4.1.2 New Offerings
- 4.1.3 Partnerships, Alliances, and Business Expansions
- 4.1.4 Mergers and Acquisitions
- 4.1.5 Funding Activities
- 4.2 Market Share Analysis
- 4.2.1 Company
- 4.2.2 Neuromicroscopy
- 4.2.3 Neuronavigation
- 4.2.4 Neuroendoscopy
- 4.2.5 Neurosurgical Robotics
- 4.3 Growth Share Analysis
- 4.3.1 Product Type
- 4.3.2 Region
5 Industry Insights
- 5.1 Legal Regulations
- 5.1.1 U.S.
- 5.1.2 European Union (EU)
- 5.1.3 China
- 5.1.4 Japan
- 5.2 Impact of COVID-19
- 5.3 Awaited Technological Developments
- 5.3.1 Age of Augmented Reality (AR) Integration
- 5.4 Patent Analysis
- 5.4.1 Patent Filing Trends
- 5.4.2 Patent Filing Trend (by Product Type)
- 5.4.3 Patent Filing Trend (by Country)
- 5.4.4 Impact of Patent Expiration
- 5.5 Minimally Invasive Surgeries: Opportunity Analysis
- 5.5.1 Pre-COVID-19 Scenario
- 5.5.2 Post-COVID-19 Scenario
6 Market Dynamics
- 6.1 Impact Analysis
- 6.2 Market Drivers
- 6.2.1 Increasing Elderly Population on the Global Level Propels the Demand for Minimally Invasive Neurosurgical Procedures
- 6.2.2 Advantages of Minimally Invasive Neurosurgical Procedures Over Conventional Open Surgical Procedures
- 6.2.3 Availability of Technological Advanced Products in the Field of Neurosurgical Procedures
- 6.3 Market Restraints
- 6.3.1 Lack of Skilled Professionals
- 6.3.2 Restrictive Reimbursement Framework
- 6.4 Market Opportunities
- 6.4.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
- 6.4.1.1 Advantages of Long-Distance Teleoperated Surgical Robotics
7 Global Minimally Invasive Neurosurgical Systems Market Scenario
- 7.1 Global Market Outlook, 2019-2030
- 7.2 Key Findings
- 7.3 Assumptions and Limitations
8 Global Minimally Invasive Neurosurgical Systems Market (by Product Type), 2019-2030
- 8.1 Market Overview
- 8.2 Neuromicroscopy
- 8.2.1 Overview
- 8.2.2 Market Size and Forecast
- 8.3 Neuronavigation
- 8.3.1 Overview
- 8.3.2 Market Size and Forecast
- 8.3.3 Optical Neuronavigation Systems
- 8.3.4 Electromagnetic Neuronavigation Systems
- 8.4 Neuroendoscopy
- 8.4.1 Overview
- 8.4.2 Market Size and Forecast
- 8.4.3 Rigid Neuroendoscopy Systems
- 8.4.4 Flexible Neuroendoscopy Systems
- 8.5 Neurosurgical Robotics
- 8.5.1 Overview
- 8.5.2 Market Size and Forecast
- 8.5.3 Systems (Capital Equipment)
- 8.5.4 Instruments and Accessories
- 8.5.5 Services
9 Global Minimally Invasive Neurosurgical Systems Market (by Region), 2019-2030
- 9.1 Market Overview
- 9.2 North America
- 9.2.1 Opportunity Assessment
- 9.2.2 Market Size and Forecast
- 9.2.3 U.S.
- 9.2.4 Canada
- 9.3 Europe
- 9.3.1 Opportunity Assessment
- 9.3.2 Market Size and Forecast
- 9.3.3 Germany
- 9.3.4 France
- 9.3.5 U.K.
- 9.3.6 Italy
- 9.3.7 Spain
- 9.3.8 Netherlands
- 9.3.9 Switzerland
- 9.3.10 Rest-of-Europe
- 9.4 Asia-Pacific
- 9.4.1 Opportunity Assessment
- 9.4.2 Market Size and Forecast
- 9.4.3 Japan
- 9.4.4 China
- 9.4.5 South Korea
- 9.4.6 India
- 9.4.7 Australia and New Zealand
- 9.4.8 Singapore
- 9.4.9 Rest-of-Asia-Pacific
- 9.5 Rest-of-the-World (Latin America and Middle East and Africa)
- 9.5.1 Opportunity Assessment
- 9.5.2 Market Size and Forecast
10 Company Profiles
- 10.1 Overview
- 10.2 Corindus Vascular Robotics, Inc. (Siemens Healthineers AG)
- 10.2.1 Company Overview
- 10.2.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.2.3 Financials
- 10.2.4 SWOT Analysis
- 10.3 Microbot Medical, Inc.
- 10.3.1 Company Overview
- 10.3.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.3.3 SWOT Analysis
- 10.4 Synaptive Medical, Inc.
- 10.4.1 Company Overview
- 10.4.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.4.3 SWOT Analysis
- 10.5 Stryker Corporation
- 10.5.1 Company Overview
- 10.5.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.5.3 Financials
- 10.5.4 SWOT Analysis
- 10.6 Zimmer Biomet Holdings, Inc.
- 10.6.1 Company Overview
- 10.6.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.6.3 Financials
- 10.6.4 SWOT Analysis
- 10.7 B. Braun Melsungen AG
- 10.7.1 Company Overview
- 10.7.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.7.3 Financials
- 10.7.4 SWOT Analysis
- 10.8 Olympus Corporation
- 10.8.1 Company Overview
- 10.8.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.8.3 Financials
- 10.8.4 SWOT Analysis
- 10.9 Renishaw plc
- 10.9.1 Company Overview
- 10.9.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.9.3 Financials
- 10.9.4 SWOT Analysis
- 10.1 Medtronic plc
- 10.10.1 Company Overview
- 10.10.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.10.3 Financials
- 10.10.4 SWOT Analysis
- 10.11 Leica Microsystems (Danaher Corporation)
- 10.11.1 Company Overview
- 10.11.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.11.3 Financials
- 10.11.4 SWOT Analysis
- 10.12 Carl Zeiss AG
- 10.12.1 Company Overview
- 10.12.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.12.3 Financials
- 10.12.4 SWOT Analysis
- 10.13 Haag-Streit Holding AG (Metall Zug AG)
- 10.13.1 Company Overview
- 10.13.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.13.3 Financials
- 10.13.4 SWOT Analysis
- 10.14 Karl Storz SE & Co. KG
- 10.14.1 Company Overview
- 10.14.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.14.3 SWOT Analysis
- 10.15 Brainlab AG
- 10.15.1 Company Overview
- 10.15.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.15.3 SWOT Analysis
- 10.16 Monteris Medical Corporation
- 10.16.1 Company Overview
- 10.16.2 Role of the Company in the Minimally Invasive Neurosurgical Systems Market
- 10.16.3 SWOT Analysis
比較リスト
